Status:

ENROLLING_BY_INVITATION

Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections

Lead Sponsor:

University of Colorado, Denver

Collaborating Sponsors:

University of Rochester

Conditions:

Staphylococcus Aureus Infection

Surgical Site Infection

Eligibility:

All Genders

18-85 years

Brief Summary

The goal of this study is to test a new way to diagnose and track treatment of spine infections caused by the bacteria Staphylococcus aureus.

Detailed Description

Ongoing Staphylococcus aureus (S. aureus) infections of the spine associated with orthopedic hardware implants elicit prominent immune responses against a repertoire of proteins characteristic of the ...

Eligibility Criteria

Inclusion

  • patients with known or suspected spinal infections associated with spinal orthopedic implant(s);
  • patients over 18 years of age and younger than 85;
  • patients undergoing spinal revision surgery.

Exclusion

  • Diagnosed as immuno-compromised or immuno-suppressed based on medication use;
  • On-going or previously diagnosed musculoskeletal infections associated non-spine hardware (e.g., prosthetic hip, prosthetic knee, prosthetic shoulder);
  • Current diabetic foot ulcer/infection;
  • Patients undergoing cancer treatment (including radiation and chemotherapies);
  • Pregnancy;
  • Absence of a spleen;
  • Over the age of 85 or under the age of 18.
  • Weigh less than 110 pounds, or for which it would otherwise be unsafe for them to undergo a blood draw.

Key Trial Info

Start Date :

August 24 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04897971

Start Date

August 24 2021

End Date

May 1 2026

Last Update

April 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Univeristy of Colorado Denver

Aurora, Colorado, United States, 80045